Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03281954
Title Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors NSABP Foundation Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.